Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen

Detalhes bibliográficos
Autor(a) principal: Bartlewski, Pawel M.
Data de Publicação: 2015
Outros Autores: Seaton, Patricia, Szpila, Patrycja, Oliveira, Maria E. F. [UNESP], Murawski, Maciej, Schwarz, Tomasz, Kridli, Rami T., Zieba, Dorota A.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1016/j.theriogenology.2015.07.002
http://hdl.handle.net/11449/158487
Resumo: Follicular wave status at the beginning of exogenous FSH administration is an important contributor to variability in superovulatory responses in ruminants. Studies in ewes have shown a decrease in the number of ovulations when superovulation is initiated in the presence of ostensibly ovulatory-sized ovarian follicles. Hormonal ablation of large antral follicles with the progestin-estradiol (E-2-17 beta) treatment significantly reduces this variability in superovulated anestrous ewes, but the effects of the treatment in cycling ewes have not yet been assessed. Sixteen Rideau Arcott x Polled Dorset ewes (November-December) received either medroxyprogesterone acetate (MAP)-releasing intravaginal sponges (60 mg) or controlled internal drug release (CIDR) devices (containing 300 mg of natural progesterone) for 14 days (Days 0-14), with a single intramuscular injection of 350 mu g of E-2-17 beta on Day 6. The superovulatory treatment consisted of six injections of porcine FSH (Folltropin-V) given twice daily, followed by a bolus GnRH injection (50 mu g intramuscular) on Day 15. There were no differences (P < 0.05) in the ovulatory responses and embryo yields between the two groups of ewes. In both subsets of animals, the next follicular wave emerged similar to 2.5 days after an E-2-17 beta injection (P > 0.05). A decline in maximum follicle size after an E-2-17 beta injection was more abrupt in CIDR- compared with MAP-treated animals, and the ewes pretreated with exogenous progesterone had significantly more 3-mm follicles at the start of the superovulatory treatment. The metabolic clearance rate of exogenous E-2-17 beta appeared to be greater in MAP-treated ewes, but circulating concentrations of porcine FSH failed to increase significantly after each Folltropin-V injection in CIDR-treated animals. The CIDR-treated ewes exceeded (P < 0.05) their MAP-treated counterparts in serum E-2-17 beta concentrations during superovulation. In spite of differences in antral follicle numbers and endocrine profiles between MAP- and CIDR-treated cyclic ewes receiving E-2-17 beta before ovarian superstimulation, there were no differences in superovulatory responses. (C) 2015 Elsevier Inc. All rights reserved.
id UNSP_d8a1309676afe3a98d6529da639b1133
oai_identifier_str oai:repositorio.unesp.br:11449/158487
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimenSheepProgestinEstradiolSuperovulationAntral follicleUltrasonographyFollicular wave status at the beginning of exogenous FSH administration is an important contributor to variability in superovulatory responses in ruminants. Studies in ewes have shown a decrease in the number of ovulations when superovulation is initiated in the presence of ostensibly ovulatory-sized ovarian follicles. Hormonal ablation of large antral follicles with the progestin-estradiol (E-2-17 beta) treatment significantly reduces this variability in superovulated anestrous ewes, but the effects of the treatment in cycling ewes have not yet been assessed. Sixteen Rideau Arcott x Polled Dorset ewes (November-December) received either medroxyprogesterone acetate (MAP)-releasing intravaginal sponges (60 mg) or controlled internal drug release (CIDR) devices (containing 300 mg of natural progesterone) for 14 days (Days 0-14), with a single intramuscular injection of 350 mu g of E-2-17 beta on Day 6. The superovulatory treatment consisted of six injections of porcine FSH (Folltropin-V) given twice daily, followed by a bolus GnRH injection (50 mu g intramuscular) on Day 15. There were no differences (P < 0.05) in the ovulatory responses and embryo yields between the two groups of ewes. In both subsets of animals, the next follicular wave emerged similar to 2.5 days after an E-2-17 beta injection (P > 0.05). A decline in maximum follicle size after an E-2-17 beta injection was more abrupt in CIDR- compared with MAP-treated animals, and the ewes pretreated with exogenous progesterone had significantly more 3-mm follicles at the start of the superovulatory treatment. The metabolic clearance rate of exogenous E-2-17 beta appeared to be greater in MAP-treated ewes, but circulating concentrations of porcine FSH failed to increase significantly after each Folltropin-V injection in CIDR-treated animals. The CIDR-treated ewes exceeded (P < 0.05) their MAP-treated counterparts in serum E-2-17 beta concentrations during superovulation. In spite of differences in antral follicle numbers and endocrine profiles between MAP- and CIDR-treated cyclic ewes receiving E-2-17 beta before ovarian superstimulation, there were no differences in superovulatory responses. (C) 2015 Elsevier Inc. All rights reserved.Natural Sciences and Engineering Research Council of CanadaJordan University of Science and TechnologyUniv Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, CanadaAgr Univ Krakow, Dept Anim Biotechnol, Krakow, PolandSao Paulo State Univ, Dept Preventat Vet Med & Anim Reprod, Coll Agr & Vet Sci, Sao Paulo, BrazilAgr Univ Krakow, Inst Anim Sci, Krakow, PolandJordan Univ Sci & Technol, Dept Anim Prod, Irbid, JordanSao Paulo State Univ, Dept Preventat Vet Med & Anim Reprod, Coll Agr & Vet Sci, Sao Paulo, BrazilNatural Sciences and Engineering Research Council of Canada: 400301Elsevier B.V.Univ GuelphAgr Univ KrakowUniversidade Estadual Paulista (Unesp)Jordan Univ Sci & TechnolBartlewski, Pawel M.Seaton, PatriciaSzpila, PatrycjaOliveira, Maria E. F. [UNESP]Murawski, MaciejSchwarz, TomaszKridli, Rami T.Zieba, Dorota A.2018-11-26T15:27:51Z2018-11-26T15:27:51Z2015-10-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article1225-1237application/pdfhttp://dx.doi.org/10.1016/j.theriogenology.2015.07.002Theriogenology. New York: Elsevier Science Inc, v. 84, n. 7, p. 1225-1237, 2015.0093-691Xhttp://hdl.handle.net/11449/15848710.1016/j.theriogenology.2015.07.002WOS:000361077700021WOS000361077700021.pdfWeb of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengTheriogenologyinfo:eu-repo/semantics/openAccess2023-12-21T06:25:00Zoai:repositorio.unesp.br:11449/158487Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-12-21T06:25Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
title Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
spellingShingle Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
Bartlewski, Pawel M.
Sheep
Progestin
Estradiol
Superovulation
Antral follicle
Ultrasonography
title_short Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
title_full Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
title_fullStr Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
title_full_unstemmed Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
title_sort Comparison of the effects of pretreatment with Veramix sponge (medroxyprogesterone acetate) or CIDR (natural progesterone) in combination with an injection of estradiol-17 beta on ovarian activity, endocrine profiles, and embryo yields in cyclic ewes superovulated in the multiple-dose Folltropin-V (porcine FSH) regimen
author Bartlewski, Pawel M.
author_facet Bartlewski, Pawel M.
Seaton, Patricia
Szpila, Patrycja
Oliveira, Maria E. F. [UNESP]
Murawski, Maciej
Schwarz, Tomasz
Kridli, Rami T.
Zieba, Dorota A.
author_role author
author2 Seaton, Patricia
Szpila, Patrycja
Oliveira, Maria E. F. [UNESP]
Murawski, Maciej
Schwarz, Tomasz
Kridli, Rami T.
Zieba, Dorota A.
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Guelph
Agr Univ Krakow
Universidade Estadual Paulista (Unesp)
Jordan Univ Sci & Technol
dc.contributor.author.fl_str_mv Bartlewski, Pawel M.
Seaton, Patricia
Szpila, Patrycja
Oliveira, Maria E. F. [UNESP]
Murawski, Maciej
Schwarz, Tomasz
Kridli, Rami T.
Zieba, Dorota A.
dc.subject.por.fl_str_mv Sheep
Progestin
Estradiol
Superovulation
Antral follicle
Ultrasonography
topic Sheep
Progestin
Estradiol
Superovulation
Antral follicle
Ultrasonography
description Follicular wave status at the beginning of exogenous FSH administration is an important contributor to variability in superovulatory responses in ruminants. Studies in ewes have shown a decrease in the number of ovulations when superovulation is initiated in the presence of ostensibly ovulatory-sized ovarian follicles. Hormonal ablation of large antral follicles with the progestin-estradiol (E-2-17 beta) treatment significantly reduces this variability in superovulated anestrous ewes, but the effects of the treatment in cycling ewes have not yet been assessed. Sixteen Rideau Arcott x Polled Dorset ewes (November-December) received either medroxyprogesterone acetate (MAP)-releasing intravaginal sponges (60 mg) or controlled internal drug release (CIDR) devices (containing 300 mg of natural progesterone) for 14 days (Days 0-14), with a single intramuscular injection of 350 mu g of E-2-17 beta on Day 6. The superovulatory treatment consisted of six injections of porcine FSH (Folltropin-V) given twice daily, followed by a bolus GnRH injection (50 mu g intramuscular) on Day 15. There were no differences (P < 0.05) in the ovulatory responses and embryo yields between the two groups of ewes. In both subsets of animals, the next follicular wave emerged similar to 2.5 days after an E-2-17 beta injection (P > 0.05). A decline in maximum follicle size after an E-2-17 beta injection was more abrupt in CIDR- compared with MAP-treated animals, and the ewes pretreated with exogenous progesterone had significantly more 3-mm follicles at the start of the superovulatory treatment. The metabolic clearance rate of exogenous E-2-17 beta appeared to be greater in MAP-treated ewes, but circulating concentrations of porcine FSH failed to increase significantly after each Folltropin-V injection in CIDR-treated animals. The CIDR-treated ewes exceeded (P < 0.05) their MAP-treated counterparts in serum E-2-17 beta concentrations during superovulation. In spite of differences in antral follicle numbers and endocrine profiles between MAP- and CIDR-treated cyclic ewes receiving E-2-17 beta before ovarian superstimulation, there were no differences in superovulatory responses. (C) 2015 Elsevier Inc. All rights reserved.
publishDate 2015
dc.date.none.fl_str_mv 2015-10-15
2018-11-26T15:27:51Z
2018-11-26T15:27:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.theriogenology.2015.07.002
Theriogenology. New York: Elsevier Science Inc, v. 84, n. 7, p. 1225-1237, 2015.
0093-691X
http://hdl.handle.net/11449/158487
10.1016/j.theriogenology.2015.07.002
WOS:000361077700021
WOS000361077700021.pdf
url http://dx.doi.org/10.1016/j.theriogenology.2015.07.002
http://hdl.handle.net/11449/158487
identifier_str_mv Theriogenology. New York: Elsevier Science Inc, v. 84, n. 7, p. 1225-1237, 2015.
0093-691X
10.1016/j.theriogenology.2015.07.002
WOS:000361077700021
WOS000361077700021.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Theriogenology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1225-1237
application/pdf
dc.publisher.none.fl_str_mv Elsevier B.V.
publisher.none.fl_str_mv Elsevier B.V.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1792962139504246784